Cancer Genetics Professional Education in a Global Community of Practice

技术和治疗的进步产生了前所未有的基因组信息的注入 进入临床实践，进一步推动了对熟练劳动力的需求， 在乎最近的国家调查表明，对熟练工人的需求与可得性之间仍然存在差距， 基因组癌症风险评估（GCRA）临床医生。R25提案将继续使命 临床癌症基因组学和实践社区（CCGCoP），以帮助满足日益增长的需求， 有能力进行循证癌症基因组学治疗的临床医生。CCGCoP使用理论框架 情境学习，学术癌症中心的资源和专业知识，以及杰出的 广泛认可的思想领袖，为临床医生提供GCRA的多模式跨专业课程 在GCRA服务有限的不同社区执业。在目前的项目期间，我们充分 开发了基于网络的GCRA案例会议，作为基于案例的技能发展的中心来源， 课程，并将课程交付转换为双轨模式（全方位的面对面研讨会， 全频谱内容（仅通过距离），这使我们能够超过预计的按比例增加的应计费用， 确保所有参与者都能收到涵盖癌症遗传综合征所有方面的内容。 在本项目期间，来自不同实践环境的411名临床医生完成了课程或 19%是代表性不足的少数民族（14%是西班牙裔，5%是非洲裔美国人）， 10%为亚洲人; 54%（223）为社会经济服务不足的患者群体提供临床服务， 12%（50）在低收入/中等收入国家执业。完全权责发生制，有强有力的评价组成部分 记录在知识、技能和实践变化方面的重大收获，进一步支持 CCGCoP作为一个强大的教育资源，帮助临床医生理解，解释和整合复杂的 基因组信息到病人护理中。参加两个课程轨道的学员的可比收益支持了 通过实施纯远程课程，进一步提高CCGCoP的能力和覆盖面的潜力， 假设我们的学习管理平台效率更高。在R25支持下，CCGCoP 作为GCRA专业教育的旗手获得国际认可，促进改善 患者获得GCRA服务。CCGCoP校友代表了一个独特的合格的临床医生社区 在所有50个州和27个国家。建议的目标是：1）继续现有的CCGCoP密集型 2）审查和更新课程设置，并将内容映射到跨专业的GCRA能力; 3)发展协作学习门户网站，并增加额外的学术GCRA案例会议论坛; 4） 更新课程评估工具，开发新的基于能力的诊断方法，以评估学习情况 以及对以患者为中心的结果的影响。CCGCoP计划利用基因组发现的前景 通过促进优质护理的专业学习，减少遗传性癌症的影响。

Technological and therapeutic advances have generated an unprecedented infusion of genomic information into clinical practice, further fueling the need for a skilled workforce to navigate genomically-informed patient care. Recent national surveys document the continued gap between the need for, and availability of, skilled genomic cancer risk assessment (GCRA) clinicians. This R25 proposal is to continue the mission of the Clinical Cancer Genomics and Community of Practice (CCGCoP) to help address the growing demand for clinicians competent in evidence-based cancer genomics care. The CCGCoP uses the theoretical framework of situated learning, the resources and expertise of the academic cancer center, and a distinguished faculty of widely-recognized thought leaders to deliver a multimodal inter-professional course in GCRA to clinicians practicing in diverse communities with limited access to GCRA services. In the current project period we fully developed web-based GCRA case conferencing as the central source of case-based skills development for the course and converted the course delivery to a two-track model (full spectrum with face-to-face workshops, and full spectrum content via distance only), which enabled us to exceed projected scaled up accrual, while ensuring that all participants would receive content covering the full spectrum of cancer genetics syndromes. During the current project period, 411 clinicians from diverse practice settings have completed the course or are currently in session; 19% were underrepresented minorities (14% Hispanic, 5% African American) and 10% were Asian; 54% (223) provide clinical services to socio-economically underserved patient populations, and 12% (50) practice in low/middle income countries. Full accrual, with a strong evaluation component documenting significant gains in knowledge, skills and practice change, further support the efficacy of the CCGCoP as a powerful educational resource to help clinicians understand, interpret and integrate complex genomic information into patient care. Comparable gains by participants in both course tracks supports the potential to further increase capacity and reach of the CCGCoP through distance-only course implementation, assuming additional efficiencies in our learning management platforms. With R25 support, the CCGCoP has attained international recognition as a standard-bearer in GCRA professional education, facilitating improved patient access to GCRA services. The CCGCoP alumni represent a uniquely qualified community of clinicians across all 50 states and 27 countries. The proposal aims are: 1) Continue the established CCGCoP intensive course; 2) Review and update course curriculum, and map content to inter-professional GCRA competencies; 3) Evolve the collaborative learning portal and add additional academic GCRA case conference forums; 4) Update course assessment instruments and develop new competencies-based diagnostics to assess learning and impact on patient-centered outcomes. The CCGCoP initiative leverages the promise of genomic discovery to reduce the impact of hereditary cancers through professional learning that promotes quality care.